When people discuss the London Health Commission, the conversation almost always starts and ends with one name: Lord Ara Darzi. But the Commission was never a one-person operation. It was convened by the then Mayor of London, Boris Johnson, in September 2013 as an independent inquiry, and the panel behind it drew from across London’s health and civic landscape. Understanding who actually sat on that panel — and how the Commission gathered its evidence — explains why Better Health for London carried the weight it did when it was published in October 2014.
An Independent Inquiry, Convened Rather Than Elected
The London Health Commission was not a permanent institution and it was not a committee of elected officials. It was a time-limited, independent inquiry, established at the Mayor’s invitation and reporting directly to him. Lord Darzi — Co-Director of the Institute of Global Health Innovation at Imperial College London and holder of the Paul Hamlyn Chair of Surgery — was asked to lead it. That structure matters for how the Commission’s membership should be read: this was not a standing NHS body with a fixed constitutional membership, but a convened panel assembled specifically to examine how health and healthcare in London could be improved, with a defined start and end point.
The Sectors Represented on the Panel
Public accounts of the Commission describe its representation as deliberately broad rather than narrowly clinical. The panel and its supporting advisory structure drew on people connected to:
| Sector | Role in the inquiry |
|---|---|
| Local government | London boroughs and the Greater London Authority, representing the civic and place-based side of health |
| NHS England | National oversight of commissioning and service standards |
| Public Health England | Population-level health protection and prevention expertise |
| London’s healthcare commissioners and providers | The organisations actually responsible for planning and delivering care across the capital |
| Patient representatives | The lived experience of using London’s health services |
| The voluntary sector | Community and charitable organisations working alongside statutory services |
| Industry | Wider expertise from outside the public health system |
This spread was not incidental. A commission built to recommend changes across primary care, hospital reconfiguration, mental health, and the wider determinants of health — housing, air quality, employment — needed input from people who actually worked in each of those domains, not a single specialist perspective extended to cover all of them.
How the Commission Built Its Membership Into a Wider Process
The panel’s composition was only the starting point. The Commission ran a genuinely large public and professional engagement exercise underneath it: gathering views from over 9,000 people, running more than 50 roadshow and NHS-based events across London, receiving around 250 written evidence submissions, and holding nine oral hearing sessions. That scale of engagement is part of why the Commission is usually described as a broad-based inquiry rather than an expert committee working in isolation — the panel’s own cross-sector make-up was reinforced by a deliberately wide net cast for public and professional testimony.
Why the Composition Mattered for Credibility
A recommendation body drawing recommendations across a whole city’s health system faces an obvious risk: that its conclusions reflect the priorities of whichever sector dominates the room. A commission staffed only by clinicians risks recommendations skewed toward acute care; one staffed only by commissioners risks recommendations skewed toward cost and structure. By pulling from local government, national health bodies, providers, patients, the voluntary sector, and industry simultaneously, the Commission’s structure was built to counter that risk — at least in intent. Whether that balance held up in the resulting recommendations is a separate question from whether the composition itself was genuinely broad, but the breadth on paper is well documented and is a meaningful part of how the Commission’s findings were received at the time.
Reading the Panel a Decade Later
Revisiting who sat on the London Health Commission is useful for reasons beyond historical curiosity. It clarifies what kind of body actually produced Better Health for London: not a permanent NHS institution, not a single academic’s personal report, but a time-bound, Mayor-convened inquiry with genuinely mixed representation and an unusually large evidence-gathering exercise behind it. That distinction matters when weighing how much institutional continuity exists between the 2014 Commission and anything that has followed it — the panel itself no longer exists in the form it took in 2013-14, but the sectors it drew from remain the same ones still shaping how London’s health system is discussed today.